Article
Transitioning from native to synthetic receptors: broadening T-cell engineering and beyond
6 Jun 2025
Abstract excerpt
T-cell immunotherapy has progressed rapidly, evolving from native T-cell receptor biology to the development of innovative synthetic receptors that extend therapeutic applications beyond cancer. This review explores engineering strategies, ranging from natural TCRs to synthetic receptors, that increase T-cell activation and therapeutic potential. We begin by highlighting the foundational role of native receptors...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
